ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Psychiatry

Top Psychiatry Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARILYN LACHMAN MD

Psychiatry

19,186

$2.35M

692
103 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $130

SYED AFTAB MD

Psychiatry

17,430

$2.65M

735
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$152
Average prescription price

Avg: $130

FERNANDO LOPEZ M.D.

Psychiatry

16,791

$1.81M

1069
165 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$108
Average prescription price

Avg: $130

HEATHER ROWE M.D.

Psychiatry

15,641

$2.32M

764
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $130

MARINO TULAO MD

Psychiatry

12,315

$2.01M

621
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $130

KAZI AHMAD M.D.

Psychiatry

11,583

$2.08M

684
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $130

GEORGIE STANFORD M.D.

Psychiatry

11,433

$1.5M

701
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $130

TERRI STEELE M.D.

Psychiatry

11,416

$1.71M

659
123 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $130

MARIANNE SAITZ D.O

Psychiatry

11,043

$2.09M

863
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $130

RICHARD GRANT M.D.

Psychiatry

10,422

$1.29M

606
61 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $130

WOLFRAM GLASER MD

Psychiatry

9,944

$1.9M

486
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$191
Average prescription price

Avg: $130

ANUPAMA YEDLA MD

Psychiatry

9,347

$1.38M

557
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $130

JOHN STRUNK M.D.

Psychiatry

9,275

$1.17M

606
239 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $130

JOSEPH LUCAS M.D.

Psychiatry

8,733

$755K

713
214 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $130

JAMES JEFFERY MD

Psychiatry

8,553

$833K

423
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $130

DAVID HARVEY MD

Psychiatry

8,550

$830K

502
142 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $130

DONNA EARNSHAW M.D.

Psychiatry

8,228

$1.48M

402
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $130

MAURICE JETER MD

Psychiatry

7,792

$1.32M

413
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$170
Average prescription price

Avg: $130

WARREN SCOTT M.D.

Psychiatry

7,730

$730K

514
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $130

KUMBLA LAKSHMIKANTHA M.D.

Psychiatry

7,522

$1.08M

327
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $130

JANET LINTON MD

Psychiatry

7,465

$917K

521
152 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$123
Average prescription price

Avg: $130

DAVID ANAKWENZE M.D.

Psychiatry

7,025

$746K

323
48 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$106
Average prescription price

Avg: $130

PRAVEEN JETTY M.D.

Psychiatry

6,975

$1.07M

450
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 24%

$154
Average prescription price

Avg: $130

ARMAND SCHACHTER MD

Psychiatry

6,953

$780K

498
146 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $130

TIMOTHY BALTZ MD

Psychiatry

6,942

$849K

483
61 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $130

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank